基本信息
浏览量:570
职业迁徙
个人简介
John Thompson has been Professor of Melanoma and Surgical Oncology at the University of Sydney since 1999. He was Executive Director of Melanoma Institute Australia (formerly the Sydney Melanoma Unit), one of the world’s largest melanoma treatment and research centres, from 1998 to 2016. A pioneer of the sentinel lymph node biopsy procedure, he is a past President of the International Sentinel Node Society. He also developed the isolated limb infusion technique of regional chemotherapy for melanoma and soft-tissue sarcoma. He has been elected as an Honorary Fellow of the American College of Surgeons, the American Surgical Association and the Australian Academy of Health and Medical Sciences. He was Chairman of the Australian and New Zealand Melanoma Trials Group from 2002-2013 and currently chairs the Australian Melanoma Management Guidelines Working Party (since 2013).
Professor Thompson has authored 785 peer-reviewed scientific articles and book chapters, edited 11 books, and served on the editorial boards of several major international journals. In 2014 Professor Thompson was made an Officer of the Order of Australia (AO) “for distinguished service to medicine in the field of oncology research, particularly melanoma, to international and national professional organisations, and to medical education.”
Professor Thompson has authored 785 peer-reviewed scientific articles and book chapters, edited 11 books, and served on the editorial boards of several major international journals. In 2014 Professor Thompson was made an Officer of the Order of Australia (AO) “for distinguished service to medicine in the field of oncology research, particularly melanoma, to international and national professional organisations, and to medical education.”
研究兴趣
论文共 263 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Future oncology (London, England)no. 2 (2023): 97-102
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn